• Summary

  • From COVID to patient engagement to new tech, we're talking everything genomics.
    Copyright 2021 All rights reserved.
    Show more Show less
  • Aug 10 2022

    "It's so important to have companies that represent [black] people. Because if you see people like you, who look like you, you're gonna feel like they have your best intentions."

    On Today's episode of The G Word, Sophia, the Design Researcher for our Diverse Data team, is joined by Professor Martin Levermore, hub member and pioneer of the programme, alongside two of the programme's interns, Samuel and Mbasan. 

    They discuss the need for black talents in genomics and how the Black Internship Programme is breaking barriers to enable the diversification process. They also discuss the importance of representation when asking for sensitive information from unrepresented communities, breaking the distrust to gain a broader insight into our genomic data. 

    Show more Show less
    47 mins
  • Aug 3 2022

    "Every disease is a rare disease because it's a disease in you, and it's interacting with you. So, this idea that there are rare diseases, and there are common diseases, [is] kind of nonsense because everything is rare in the context of a given human being."

    On today's episode of The G Word, our CEO, Chris Wigley, is joined by Dr Lucy McKay, CEO and founder of Medics for Rare Diseases. Medics for Rare Diseases is a grassroots charity created to change the attitude towards rare diseases and changing the ground for people with rare diseases. 

    Together, they discuss Lucy's genomics background, delving into her personal relationship to rare disease through her brother and how a conversation at the dinner table with her parents opened the door to many opportunities. They also cover the impact of using terminology such as 'disease' and 'rare' towards patients and in classrooms. 

    Show more Show less
    38 mins
  • Jul 27 2022

     "In cancer, it's been more challenging, because we had to get a community that hadn't really worked on the scale of data at all, to come to terms with that."

    On today's episode, Matt Brown, our Chief Scientific Officer at Genomics England is joined by professor Sir Mark Caulfield, one of the founding employees of Genomics England and predecessor to Matt Brown as Chief Scientific Officer. 

    Today, they'll be discussing Mark's recollections of his time as Chief Scientific Officer of Genomics England, and his thoughts about pharmacogenomics' future.

    Show more Show less
    39 mins

What listeners say about The G Word

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.